However, the aberrant activation or inhibition of Wnt5a signaling is emerging as an important event in cancer progression, exerting both oncogenic and tumor-suppressive effects (Astudillo, 2020; Menck et al., 2021). The gene discussed is WNT5A; the disease is neoplasm.